{"id":"W3016616745","doi":"10.1007/s40262-020-00888-w","title":"Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Astellas Pharma","keywords":"Pharmacokinetics; Pharmacology; Chemistry; Medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006588439,0.0003985757,0.00105767,0.0001296462,0.00005738078,0.00002352811,0.0004951298,0.0002497385,0.002254609],"category_scores_gemma":[0.001771986,0.0003622068,0.0004525606,0.0008469447,0.0006733862,0.00009379428,0.0004740985,0.001401891,0.0003855521],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000759804,"about_ca_system_score_gemma":0.0004378688,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000640075,"about_ca_topic_score_gemma":1.711384e-7,"domain_scores_codex":[0.9958437,0.0001694801,0.001734149,0.0007897328,0.0007966581,0.0006662601],"domain_scores_gemma":[0.9967486,0.0005386563,0.0003367455,0.0005202808,0.000585278,0.001270499],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003435645,0.001884154,0.005978955,0.001040512,0.0003059127,0.0003123257,0.0001504923,0.00003175346,0.8355325,0.00007430497,0.1215759,0.02967754],"study_design_scores_gemma":[0.0375126,0.004492305,0.01205428,0.0003749477,0.001151968,0.0001159735,0.00009333976,0.0502397,0.5891349,0.00003063607,0.3039742,0.0008251022],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9619626,0.001044284,0.002317692,0.0228732,0.001008727,0.002379051,0.0004590662,0.0003742711,0.007581064],"genre_scores_gemma":[0.9727931,0.0007603891,0.01076592,0.01125671,0.003380822,0.00005299267,0.0001237299,0.0001351857,0.0007311575],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2463976,"threshold_uncertainty_score":0.999883,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1151177104315076,"score_gpt":0.4183749330103149,"score_spread":0.3032572225788073,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}